The neuropathic pain: An overview of the current treatment and future therapeutic approachesEugenio Cavalli, Emanuela Mazzon, Santa Mammana et al.|International Journal of Immunopathology and Pharmacology|2019Cited by 495
The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic TargetsSanta Mammana, Emanuela Mazzon, Paolo Fagone et al.|International Journal of Molecular Sciences|2018Cited by 167
The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19Maria Sofia Basile, Ferdinando Nicoletti, Eugenio Cavalli et al.|Drug Discovery Today|2021Cited by 119
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosisSanta Mammana, Katia Mangano, Placido Bramanti et al.|Oncotarget|2018Cited by 98
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)Eugenio Cavalli, Ferdinando Nicoletti, Alessia Bramanti et al.|International Journal of Molecular Medicine|2020Cited by 87